Stage two of the Supplemental Disaster Relief Program (SDRP) is moving into the initial stages of implementation, USDA officials announced during a media briefing on Monday. In what USDA Deputy ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Xbiome Inc., an industry leading AI driven microbiome therapeutics company, today announced that it has acquired the clinical-stage M201 program from Assembly ...
MoonLake Immunotherapeutics launched VELA-1 and VELA-2 as two studies using sonelokimab for the treatment of patients with Hidradenitis Suppurativa; Topline 16-week primary endpoint expected end of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback